Latest news with #DepartmentofNuclearMedicine
Time of India
5 days ago
- Health
- Time of India
AIIMS-R only hosp in state with advanced nuclear medicine infra
Raipur: The All India Institute of Medical Sciences (AIIMS), Raipur, installed an automated radio synthesizer and Gallium generator in its nuclear medicine department. This facility allows the institute to produce next-generation PET radiotracers in-house. AIIMS Raipur is now the only govt hospital in Chhattisgarh equipped with such advanced nuclear medicine infrastructure. The Department of Nuclear Medicine now offers advanced PET-based imaging services for early diagnosis, staging, and personalised treatment strategies. The newly available tracers include PSMA PET for prostate cancer detection, DOTA PET for imaging neuroendocrine tumours and guiding peptide receptor radionuclide therapy (PRRT), FAPI PET for cancers with low FDG uptake and fibrotic diseases, and Exendin PET for precise localisation of insulinomas. Dr Mudalsha Ravina, Associate Professor and Head, Department of Nuclear Medicine, said these radiotracers improve diagnostic accuracy, especially in complex and systemic diseases. Prof (Dr) Renu Rajguru, Medical Superintendent and Head, ENT Department, said in-house radiotracer production will enhance patient throughput, reduce reliance on external vendors, and support timely treatment decisions. Dr Shobhana Raju, Assistant Prof, Department of Nuclear Medicine, said the new Gallium-labelled tracers will usher in a new era in cancer theranostics. This will promote therapy-oriented research and pave the way for personalised cancer treatments, particularly in prostate, gastrointestinal, and breast cancers. Sai Shiv Narayan, Medical Physicist, said automation ensures consistent tracer quality, enhances radiation safety, and streamlines workflow. The department features high-end technologies including PET-CT, SPECT-CT, radioiodine uptake probe, robotic navigation for PET-guided biopsies, low-dose and high-dose therapies. The department also runs an MD nuclear medicine programme. This new facility aims to provide affordable, specialised diagnosis and treatment for patients in Chhattisgarh. Lt Gen Ashok Jindal (Retd.), Executive Director and CEO of AIIMS Raipur, said this infrastructure upgrade shows their commitment to delivering advanced, affordable, and high-quality diagnostics in central India. He added that it complements their expanding oncology and metabolic disease services.
Time of India
6 days ago
- General
- Time of India
AIIMS Raipur is only govt hospital in Chhattisgarh equipped with advanced nuclear medicine facility
RAIPUR: The All India Institute of Medical Sciences (AIIMS), Raipur, has installed an automated radio synthesizer and Gallium generator in its nuclear medicine department. This facility will allow the institute to produce next-generation PET radiotracers in-house. Tired of too many ads? go ad free now AIIMS Raipur is now the only government hospital in Chhattisgarh equipped with such advanced nuclear medicine infrastructure. The Department of Nuclear Medicine now offers advanced PET-based imaging services for early diagnosis, staging and personalised treatment strategies. The newly available tracers include PSMA PET for prostate cancer detection, DOTA PET for imaging neuroendocrine tumours and guiding peptide receptor radionuclide therapy (PRRT), FAPI PET for cancers with low FDG uptake and fibrotic diseases, and Exendin PET for precise localisation of insulinomas. Dr Mudalsha Ravina, Associate Professor and Head, Department of Nuclear Medicine, said these radiotracers improve diagnostic accuracy, especially in complex and systemic diseases. Professor (Dr) Renu Rajguru, Medical Superintendent and Head, ENT department, said in-house radiotracer production will enhance patient throughput, reduce reliance on external vendors, and support timely treatment decisions. Dr Shobhana Raju, Assistant Professor, Department of Nuclear Medicine, said the new Gallium-labelled tracers will usher in a new era in cancer theranostics. This will promote therapy-oriented research and pave the way for personalised cancer treatments, particularly in prostate, gastrointestinal, and breast cancers. Sai Shiv Narayan, Medical Physicist, said automation ensures consistent tracer quality, enhances radiation safety, and streamlines workflow. Tired of too many ads? go ad free now The department features high-end technologies including PET-CT, SPECT-CT, radioiodine uptake probe, robotic navigation for PET-guided biopsies, low-dose and high-dose therapies. The department also runs an MD nuclear medicine programme. This new facility aims to provide affordable, specialised diagnosis and treatment for patients in Chhattisgarh. Lt. Gen. Ashok Jindal (Retd.), Executive Director and CEO of AIIMS Raipur, said this infrastructure upgrade shows their commitment to delivering advanced, affordable, and high-quality diagnostics in central India. He added that it complements their expanding oncology and metabolic disease services.
Observer
11-05-2025
- Health
- Observer
Royal Hospital achieves IAEA highest quality standards in nuclear medicine
MUSCAT: The Royal Hospital, represented by the Department of Nuclear Medicine, has completed the QUANUM programme (Quality Assurance Audit in Nuclear Medicine Practices) that was conducted by the International Atomic Energy Agency (IAEA). The programme, held from May 4 to 8, 2025, set grounds for the first nuclear medicine centre in the Sultanate of Oman that undergoes this type of international assessment. The field assessment of the centre showed an outstanding score of 92.5 per cent, exceeding the global average of 73.9 per cent and going beyond the usual range of 56.6 per cent to 87.9 per cent. — ONA
Time of India
21-04-2025
- Health
- Time of India
UAE International Nuclear Medicine Conference recommends expanding use of modern technologies in cancer treatment
Dubai: Participants in the fifth annual UAE International Conference in cooperation with the Arab Society for Nuclear Medicine , which concluded on Sunday at the Mohammed Bin Rashid University of Medicine and Health Sciences, recommended the need to strengthen specialised training and qualification programmes for medical staff, and expand the use of modern technologies in nuclear medicine, especially in the diagnosis and treatment of cancer and chronic diseases. Participants stressed that recent developments in the field of molecular imaging and radioisotope radiotherapy open up broad prospects in providing accurate and personalised health care, based on targeting infected cells without affecting healthy tissue, which reduces side effects and raises therapeutic success rates. Batoul Al Balooshi, Assistant Professor of Nuclear Medicine at Mohammed Bin Rashid University of Medicine and Health Sciences, Head of the Department of Nuclear Medicine at the Dubai Health Authority, and President of the Arab Society for Nuclear Medicine, said, "Today we are witnessing a major shift in how we deal with some types of cancer that did not respond to conventional chemotherapy or radiation, and through advanced nuclear medicine techniques, we were able to treat 15 patients from inside and outside the country with prostate tumours and endocrine tumours of the final control of tumours in all cases." She added that this progress embodies the effectiveness of nuclear medicine as a fundamental pillar in modern personalised medicine, noting that the recorded therapeutic successes reflect the integration between accurate diagnosis and targeted therapy, which enhances the chances of recovery and gives patients a better quality of life. She pointed out that the UAE has an advanced infrastructure in this field, as there are currently 14 specialised centres in nuclear medicine distributed in various emirates of the country, supported by the latest devices and technologies, making the UAE one of the leading countries regionally in this specialty. The second and final day of the conference witnessed a number of scientific and discussion sessions, which dealt with the latest developments in nuclear medicine, for the treatment of thyroid cancer and the importance of diagnostic therapy "Thyranostix", ranging from building integrated programs to the challenges of advanced oncological surgery, and the sessions discussed methods of managing differentiated thyroid cancer after radioactive iodine therapy, possible complications of treatment and ways to deal with them, in addition to reviewing modern and ancient molecular goals in this type of cancer. The sessions also touched on developments in the treatment of prostate cancer using targeted radiotherapy, discussed the prospects of this type of treatment over the next ten years, reviewed innovative concepts using new analogues to image and treat PSMA receptors, the role of Lu-PSMA 617 in the treatment of advanced cases, and discussed a scientific comparison between Lu-177 and TB-161 as promising treatment options. At the end of the conference, the experts stressed the importance of supporting joint scientific research, strengthening regional and international cooperation, as well as launching initiatives to raise community awareness of the importance of nuclear medicine in the early detection and accurate treatment of many diseases.
